Phathom Pharmaceuticals, Inc. (PHAT)
11.21
+0.06
(+0.54%)
USD |
NASDAQ |
Mar 20, 16:00
11.23
+0.02
(+0.18%)
After-Hours: 20:00
Phathom Pharmaceuticals Research and Development Expense (Quarterly) : 7.493M for Dec. 31, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| MannKind Corp. | 27.59M |
| Replimune Group, Inc. | 52.87M |
| ANI Pharmaceuticals, Inc. | 12.26M |
| Vanda Pharmaceuticals, Inc. | 29.01M |
| Ligand Pharmaceuticals, Inc. | 3.511M |